We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

251 hedge funds and large institutions have $5.08B invested in PHARMACYCLICS INC in 2014 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 97 increasing their positions, 89 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 89

4% less capital invested

Capital invested by funds: $5.29B → $5.08B (-$210M)

10% less funds holding

Funds holding: 280251 (-29)

27% less call options, than puts

Call options by funds: $112M | Put options by funds: $154M

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

47% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 58

Holders
251
Holders Change
-29
Holders Change %
-10.36%
% of All Funds
7.21%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.17%
New
31
Increased
97
Reduced
89
Closed
58
Calls
$112M
Puts
$154M
Net Calls
-$41.6M
Net Calls Change
+$30.5M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$860M +$80.1M +853,658 +10%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$695M +$98.4M +1,048,516 +16%
Ameriprise
3
Ameriprise
Minnesota
$382M +$76M +809,506 +23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$312M +$6.82M +72,715 +2%
JHIU
5
Janus Henderson Investors US
Colorado
$289M +$225M +2,394,937 +290%
Capital World Investors
6
Capital World Investors
California
$267M +$147M +1,562,700 +110%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$212M -$10.7M -114,294 -5%
Primecap Management
8
Primecap Management
California
$208M -$6.35M -67,700 -3%
BIT
9
BlackRock Institutional Trust
California
$149M +$2.02M +21,571 +1%
FAM
10
Fred Alger Management
New York
$133M +$1.2M +12,800 +0.9%
Norges Bank
11
Norges Bank
Norway
$106M +$55.5M +592,056 +100%
State Street
12
State Street
Massachusetts
$106M -$1.37M -14,584 -1%
BB
13
BB Biotech
Switzerland
$65.6M +$8.91M +95,000 +15%
Goldman Sachs
14
Goldman Sachs
New York
$63.8M -$56M -596,383 -46%
CCM
15
Cornerstone Capital Management
Minnesota
$63.5M +$18.1M +193,018 +38%
First Trust Advisors
16
First Trust Advisors
Illinois
$57.6M +$6.67M +71,125 +12%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$55.5M +$18.9M +201,119 +48%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$51.6M +$53.9M +574,900 New
Morgan Stanley
19
Morgan Stanley
New York
$49.2M +$5.59M +59,618 +12%
MAA
20
Managed Account Advisors
New Jersey
$47.5M +$11.1M +117,850 +29%
BFA
21
BlackRock Fund Advisors
California
$42.2M -$827K -8,810 -2%
Federated Hermes
22
Federated Hermes
Pennsylvania
$40.2M +$6.99M +74,524 +20%
Northern Trust
23
Northern Trust
Illinois
$37.4M -$3.94M -41,961 -9%
UBS AM
24
UBS AM
Illinois
$35.2M +$1.13M +12,083 +3%
AllianceBernstein
25
AllianceBernstein
Tennessee
$33.7M +$6.46M +68,886 +22%

PCYC Hedge Fund Activity: Q2 2014 in Review

251 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q2 2014, worth a combined $5.08B — down 4% from $5.29B a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of PCYC and 31 opened new positions — a net loss of 27 holders — while 89 trimmed existing stakes and 97 added.

The largest buyer was Janus Henderson Investors US, adding an estimated $225M. The largest seller was Columbus Circle Investors, cutting an estimated $74.7M.

  • 251 institutional investors held PHARMACYCLICS INC (PCYC) as of Q2 2014, down from 280 in Q1 2014.
  • Funds reported $5.08B of PHARMACYCLICS INC stock for Q2 2014, down 4% quarter-over-quarter.
  • 31 funds opened new PHARMACYCLICS INC positions in Q2 2014 and 58 closed out, a net change of -27 holders.
  • The largest PHARMACYCLICS INC buyer in Q2 2014 was Janus Henderson Investors US, an estimated $225M added.
  • The largest PHARMACYCLICS INC seller in Q2 2014 was Columbus Circle Investors, an estimated $74.7M sold.

Based on aggregated 13F filings for Q2 2014.